Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.640
-0.070 (-2.58%)
Nov 21, 2024, 2:53 PM EST - Market open
Boundless Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
72
Market Cap
58.87M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBOLD News
- 13 days ago - Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 16 days ago - Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire
- 6 months ago - Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights - Business Wire
- 7 months ago - Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024 - Business Wire
- 8 months ago - Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications - Business Wire